Home›Companies›Biotech & Pharma›Diverse Biotech

Diverse Biotech, Inc.

Updated Oct 27, 2026·Latest SEC filing Mar 10, 2023·Suggest an edit

About Diverse Biotech

Diverse Biotech is a private company based in Miami, Florida. It has reported $1,006,869 raised in three offerings on Form D since June 2018.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Not yetMar 10, 2023$0of $950K target0—Equity, Securities on exerciseRule 506(b)Form D ↗
Mar 12, 2019Dec 6, 2018amended Sep 4, 2019$337,869of $8.9M target1$337KEquityRule 506(b)Form D/A ↗1 earlier filing
Jun 19, 2018Jun 21, 2018$669,000of $7.5M target1$669KEquityRule 506(b)Form D ↗
Total, three offerings$1,006,869

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Diverse Biotech's Form D filed Mar 10, 2023.

JP
John Patrick
Director
PH
WF
William Fisher
Executive officer, director and promoter
PA
Philip Arlen
Director
PF

Earlier filings also listed Stella Vnook (executive officer, director and promoter, last listed Sep 2019) and Beaudon Spaulding (executive officer, director and promoter, last listed Jun 2018).

Sources

  1. SECDIVERSE BIOTECH, INC. Form D, filed Dec 6, 2018
  2. SECDIVERSE BIOTECH, INC. filing history